Guidelines for glycemic control

Clinical Cornerstone

Volumn 6, Issue 2, 2004, Pages 31-36

  Clement, Stephen ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; HAGEDORN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; METFORMIN; MIGLITOL; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ALGORITHM; ARTICLE; BLOATING; BODY WEIGHT DISORDER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REGIMEN; DRUG ERUPTION; DYSPNEA; FLATULENCE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEALTH CARE ORGANIZATION; HUMAN; HYPOGLYCEMIA; LACTIC ACIDOSIS; NAUSEA; NURSE PRACTITIONER; POSTPRANDIAL STATE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RISK BENEFIT ANALYSIS; RISK REDUCTION; TREATMENT PLANNING; VOMITING; WEIGHT GAIN;

ADMINISTRATION, ORAL; BLOOD GLUCOSE; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PRACTICE GUIDELINES;

EID: 12344298240     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(04)80052-8     Document Type: Article

References (11)

1. The Diabetes Control and Complications Trial Research Group (DCCT) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med. 329 1993 977-986
2. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854-865
3. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33) Lancet 352 1998 837-853
4. Standards of medical care in diabetes Diabetes Care 27 Suppl 1 2004 S15-S35
5. Stratton I.M. Adler A.I. Neil H.A. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study BMJ 321 2000 405-412
6. Franz M.J. Bantle J.P. Beebe C.A. et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications Diabetes Care 25 2002 148-198
7. Zinman B. Ruderman N. Campaigne B.N. et al. Physical activity/exercise and diabetes mellitus Diabetes Care 26 Suppl 1 2003 S73-S77
8. Riddle M.C. Rosenstock J. Gerich J. The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 26 2003 3080-3086
9. DeWitt D.E. Dugdale D.C. Using new insulin strategies in the outpatient treatment of diabetes: Clinical applications JAMA 289 2003 2265-2269
10. DeWitt D.E. Hirsch I.B. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: Scientific review JAMA 289 2003 2254-2264
11. LeRoith D. Levetan C.S. Hirsch I.B. Riddle M.C. Type 2 diabetes: The role of basal insulin therapy J Fam Pract. 53 2004 215-222